Cabaletta Bio, INC. 8-K Filing

Ticker: CABA · Form: 8-K · Filed: Sep 3, 2025 · CIK: 1759138

Sentiment: neutral

Filing Stats: 529 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-09-03 06:03:02

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On September 3, 2025, Cabaletta Bio, Inc. ("Cabaletta" or the "Company") posted to the "Investors & Media" section of the Company's website at www.cabalettabio.com an updated corporate presentation (the "Corporate Presentation"). A copy of the Corporate Presentation is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K. The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Cabaletta Bio, Inc. Corporate Presentation, dated September 2025, furnished herewith. 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. CABALETTA BIO, INC. Date: September 3, 2025 By: /s/ Steven Nichtberger Steven Nichtberger Chief Executive Officer and President (Principal Executive Officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing